Arrow
Arrow
Arrow
Spec. MD. Ferit Arğun
Spec. MD. Ferit Arğun
Spec. MD.

Ferit Arğun

Liv Hospital Ulus
Internal Medicine
Hospital
Please Select Hospital! Chevron Down
Choose Department
All Branches icon
Before Noon
Afternoon
You must select a hospital to make an appointment.
You can call our Call Center at 444 4 548 for available appointment slots and information.
Make an Appointment
Areas of Interests
    • Diabetes
    • Hypertension
    • Obesity treatment
    • Endocrine Diseases
    • Blood Disorders
    • Kidney diseases and failure treatment
    • Liver Diseases and Treatment of Liver Failure
    • Diagnosis and Treatment of Gastrointestinal Diseases
    • Diagnosis, Treatment, and Prevention of Allergies and Immunology
    • Management of Diagnosis and Treatment of Vitamin and Mineral Deficiency
    • Wellcare and Longevity Support
    • Cancer Screening
    • Elderly Patient Follow-up and Treatment
    • Check-Up Examination
Resume
Publications
Education:
  • Bachelor's Degree: Uludağ University Faculty of Medicine 1998 - 2005
  • Master's Degree: Istanbul Training and Research Hospital 2006 - 2011
Experience:
  • 2026: Liv Hospital Ulus Hospital
  • 2024: Medicana Zincirlikuyu Hospital
  • 2022: BAU Medical Park Göztepe Hospital
  • 2020: Private Practice
  • 2017: IAÜ VM Medical Park Florya Hospital
  • 2015: Medipol Mega Hospitals Complex 2015
  • 2012: Kanuni Sultan Süleyman Training and Research Hospital 201
  • 2011: Diyarbakır Training and Research Hospital
Articles published in international peer-reviewed journals:
  • 1. Evaluation of salusin-α and salusin-β levels in patients with type 2 diabetes mellitus and determination of the impact of severity of hyperglycemia on salusin levels.
    Argun D, Argun F, Borku Uysal B. Ir J Med Sci. 2021 Nov;190(4):1403-1411. https://doi.org/10.1007/s11845-021-02674-4
  • 2. Risk Factors for Idiopathic Granulomatous Mastitis Recurrence after Patient-Tailored Treatment: Do We Need an Escalating Treatment Algorithm?
    P Basim, Argun D, F Argun. Breast Care, 2021 https://doi.org/10.1159/000517399
  • 3. Monocyte-to-High-Density Lipoprotein Cholesterol Ratio: a Candidate Parameter for a Risk Assessment Model in COVID-19. D Argun, F Argun, P Basim- Clinical Laboratory, Vol. 68 Issue 3, p613-621. 9p.,2022
Ask our Experts!
You can contact with our experts for your questions!